Chenoweth, Meghan J.
Cox, Lisa Sanderson
Nollen, Nikki L.
Ahluwalia, Jasjit S.
Benowitz, Neal L.
Lerman, Caryn
Knight, Jo
Tyndale, Rachel F.
Funding for this research was provided by:
Canadian Institutes of Health Research (T2023973)
National Institutes of Health (CA091912, DA031815, DA020830)
Canada Research Chairs
Article History
Received: 22 December 2020
Accepted: 8 September 2021
First Online: 1 October 2021
Competing interests
: R. F. Tyndale has consulted for Quinn Emanuel and Ethismos. Dr. Benowitz has consulted with Achieve Life Sciences and Pfizer, companies that market or are developing smoking cessation medications, and has been a paid expert witness in litigation against tobacco companies. The other authors declare no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.